Keyphrases
Attention Function
16%
Attention Impairment
8%
Brain Exposure
8%
Brain Regions
8%
Cognitive Dysfunction
8%
Cognitive Function
8%
Determining Functionals
8%
Functional Status
8%
Glutamate Neurotransmission
8%
Hyperlocomotion
16%
Kinetic Interaction
8%
Locomotion
8%
Locomotor Activity
100%
Major Depressive Disorder
25%
MK-801
100%
Multimodal Antidepressants
8%
N-methyl-D-aspartate Receptor Antagonist
8%
Neurotransmission
8%
Non-competitive
8%
Non-inferiority Trial
8%
Patient Demographics
8%
Pharmacodynamics
8%
Plasma Exposure
8%
Scopolamine
8%
Signal Detection Task
100%
Task Performance
100%
Theoretical Mechanism
8%
Visual Signals
100%
Vortioxetine
100%
Neuroscience
Antidepressant
8%
Blood Plasma
8%
Cognitive Disorders
8%
Cognitive Function
8%
Dizocilpine-Induced Hyperactivity
8%
Glutamic Acid
8%
Locomotion
8%
Locomotor Activity
100%
Major Depressive Disorder
25%
NMDA Receptor Antagonist
8%
Scopolamine
8%
Synaptic Transmission
16%
Vortioxetine
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
8%
Clinical Research
8%
Cognitive Defect
8%
Dizocilpine-Induced Hyperactivity
8%
Functional Status
8%
Glutamic Acid
8%
Major Depression
25%
NMDA Receptor Antagonist
8%
Pharmacodynamics
8%
Scopolamine
8%
Vortioxetine
100%